Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant

NCT00684008 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

AML
CML
MDS

Interventions

DRUG: CYT107 - Recombinant glycosylated human interleukin 7.
DRUG: rhIL-7 (CYT107)

Sponsor

Cytheris, Inc.